
Venus Remedies Limited has informed the Exchange regarding a press release dated April 25, 2023, titled " Venus Remedies secures Marketing Authorisation from UK MHRA for Cisplatin.".
Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated April 25, 2023, titled " Venus Remedies secures Marketing Authorisation from UK MHRA for Cisplatin.".
6ix hasn’t read this filing yet.
Follow Venus Remedies into a list and get an email when it puts out news.
Follow Venus Remedies